In this week's episode of the Spine & Nerve podcast, Dr. Brian Joves and Dr. Nicolas Karvelas discuss the awesome and stimulating several days of the most recent NANS conference.  The doctors share their major takeaways from the conference.  The field of neurostimulation has advanced significantly over the years and we are at a point where we can really start to fine tune the exact form of neurostimulation for a specific patient and pathology.  The progress that has been made in regards to neurostimulation therapy has significantly increased the breadth of conditions that can be treated by neurostimulation / indications for neurostimulation.  This progress is accompanied by more and more literature demonstrating the efficacy and safety of neurostimulation, and most importantly we are seeing better and better outcomes for patients.  

 

One of the major new neurostimulation therapies is a form of spinal cord stimulation that targets Glial cells which we know play an important / critical role in the development and perpetuation of chronic pain states.  This form of spinal cord stimulation is Differential Target Multiplexed (DTM) spinal cord stimulation.  This therapy is backed by years of well done basic science research evaluating how neurostimulation can positively impact glial cell activity in the chronic pain state and consequently have a significant positive impact on an individuals symptoms, function, and health.  The preliminary data is very good for this therapy, and we will continue to analyze the research as more information / results become available.  

 

The NANS conference is always an excellent opportunity for learning and interacting with experts in the field; listen as the doctors discuss this experience and some of the exciting new research being done.

 

References:

1. Fishman M, Cordner H, Justiz R et al. Randomized Controlled Clinical Trial to Study the Effects of DTM-SCS in Treating Intractable Chronic Low Back Pain: 3 Month Results. Presentation at NANS 2020, Las Vegas, Nevada.

2. Cedeno D.L., Cass C.L., Kelley C.A., et al. Pre-clinical comparison of differential-target multiplexed scstm with low and high rate SCS. Neuromodulation 2019 22:3 (E185-)

3. Cedeno D.L., Kelley C.A., Cass C.L., et al. Pre-clinical Comparison of Differential-Target Multiplexed SCS with Low and High Rate SCS. Presentation at ASRA 2018. San Antonio, Texas.

 

 Follow our practice on Facebook at Spine & Nerve Diagnostic Center. Please leave us a comment or review- these help us to improve and provide value to more people.

Disclosure!!! Dr. Brian Joves is a speaker and researcher for companies that produce devices in this space; please see his LinkedIn profile for full details.

This podcast is for information and educational purposes only, it is not meant to be medical advice. If anything discussed may pertain to you, please seek council with your healthcare provider. The views expressed are those of the individuals expressing them, they may not represent the views of Spine & Nerve.